The pathologic description of GI xanthelasmas, which are the subepithelial accumulation of lipid-laden histiocytes, dates back to 1887. 6 The term "gastric xanthelasmas" was introduced decades later, in 1969, by Kimura et al. 7 Since then, gastric xanthelasmas have been widely reported, with a prevalence of up to 7%. 8 Esophageal xanthelasmas were first described in 1984, and since then 22 cases have been reported in the literature. 9, 10 Esophageal xanthomas are rarely larger than 5 mm, and the largest reported was 20 mm. 9 Here we present a unique esophageal lesion in which both WOS (intraepithelial lipid) and xanthelasmas (subepithelial lipid-laden histiocytes) were present within a 3.5-cm area of low-grade dysplasia in a C5M6 Barrett's lesion in a 70-year-old man who underwent upper endoscopy for chronic reflux symptoms (Video 1, available online at www.VideoGIE.org). Endoscopy demonstrated a yellow nodular Paris IIa lesion on the posterolateral wall that was 3.5 cm long. With magnification, areas with WOS and irregular microsurface (Figs. 1A-C) were visualized. In regions where the WOS was not heavily deposited, an irregular microvasculature was visible (Figs. 1D and E) on a yellowish background of the xanthelasma. This lesion was removed en bloc by endoscopic submucosal dissection (Fig. 1F) . Pathologic examination demonstrated Barrett's esophagus with low-grade dysplasia and the presence of heavy intraepithelial lipid deposits and subepithelial lipid-laden histiocytes (Fig. 2) .
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